Byrne Asset Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Byrne Asset Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,427	Closed	–	–	650
2023 Q1	$0	Hold	1,427	–	–	﹤0.01%	643
2022 Q4	$234	Buy	+1,427	New	+$597	﹤0.01%	513

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Byrne Asset Management's PLXP Position: Q2 2023 in Review

Byrne Asset Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 1,427 shares.

Byrne Asset Management first reported a position in PLXP in Q4 2022 and held it in 2 quarters. The position peaked at $234 in Q4 2022. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Byrne Asset Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Byrne Asset Management sold 1,427 PLx Pharma Inc. Common Stock shares in Q2 2023.
Byrne Asset Management first reported a position in PLx Pharma Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Byrne Asset Management's PLx Pharma Inc. Common Stock position peaked at $234 in Q4 2022.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Byrne Asset Management's 13F filing for Q2 2023, filed 21 Jul 2023.